Suppr超能文献

在小鼠中,破骨细胞对于粒细胞集落刺激因子介导的造血祖细胞动员并非必需。

Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice.

作者信息

Rao Mahil, Supakorndej Teerawit, Schmidt Amy P, Link Daniel C

机构信息

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Exp Hematol. 2015 Feb;43(2):110-4.e1-2. doi: 10.1016/j.exphem.2014.10.012. Epub 2014 Nov 1.

Abstract

The contribution of osteoclasts to hematopoietic stem/progenitor cell (HSPC) retention in the bone marrow is controversial. Studies of HSPC trafficking in osteoclast-deficient mice are limited by osteopetrosis. Here, we employed two non-osteopetrotic mouse models to assess the contribution of osteoclasts to basal and granulocyte colony-stimulating factor (G-CSF)-induced HSPC mobilization. We generated Rank(-/-) fetal liver chimeras using Csf3r(-/-) recipients to produce mice lacking G-CSF receptor expression in osteoclasts. Basal and G-CSF-induced HSPC mobilization was normal in these chimeras. We next acutely depleted osteoclasts in wild-type mice using the RANK ligand inhibitor osteoprotegerin. Marked suppression of osteoclasts was observed after a single injection of osteoprotegerin-Fc. Basal and G-CSF-induced HSPC mobilization in osteoprotegerin-Fc-treated mice was comparable to that in control mice. Together, these data indicate that osteoclasts are not required for the efficient retention of HSPCs in the bone marrow and are dispensable for HSPC mobilization by G-CSF.

摘要

破骨细胞对造血干细胞/祖细胞(HSPC)保留在骨髓中的作用存在争议。在破骨细胞缺陷小鼠中对HSPC迁移的研究受到骨质石化的限制。在此,我们采用两种非骨质石化小鼠模型来评估破骨细胞对基础和粒细胞集落刺激因子(G-CSF)诱导的HSPC动员的作用。我们使用Csf3r(-/-)受体生成Rank(-/-)胎肝嵌合体,以产生在破骨细胞中缺乏G-CSF受体表达的小鼠。这些嵌合体中的基础和G-CSF诱导的HSPC动员是正常的。接下来,我们使用RANK配体抑制剂骨保护素在野生型小鼠中急性清除破骨细胞。单次注射骨保护素-Fc后观察到破骨细胞受到明显抑制。骨保护素-Fc处理的小鼠中基础和G-CSF诱导的HSPC动员与对照小鼠相当。总之,这些数据表明破骨细胞对于HSPC在骨髓中的有效保留不是必需的,并且对于G-CSF诱导的HSPC动员是可有可无的。

相似文献

1
Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice.
Exp Hematol. 2015 Feb;43(2):110-4.e1-2. doi: 10.1016/j.exphem.2014.10.012. Epub 2014 Nov 1.
2
Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization.
J Exp Med. 2011 Oct 24;208(11):2175-81. doi: 10.1084/jem.20101890. Epub 2011 Oct 17.
5
The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells.
Stem Cells Dev. 2010 Aug;19(8):1143-51. doi: 10.1089/scd.2009.0376.
7
Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice.
J Bone Miner Res. 2004 Jul;19(7):1137-43. doi: 10.1359/JBMR.040318. Epub 2004 Mar 22.
9
HIF-1α-stabilizing agent FG-4497 rescues human CD34 cell mobilization in response to G-CSF in immunodeficient mice.
Exp Hematol. 2017 Aug;52:50-55.e6. doi: 10.1016/j.exphem.2017.05.004. Epub 2017 May 17.

引用本文的文献

1
Crosstalk between bone and the immune system.
J Bone Miner Metab. 2024 Jul;42(4):470-480. doi: 10.1007/s00774-024-01539-x. Epub 2024 Jul 26.
2
Granulocyte colony-stimulating factor (G-CSF) mediates bone resorption in periodontitis.
BMC Oral Health. 2021 Jun 12;21(1):299. doi: 10.1186/s12903-021-01658-1.
3
Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases.
Bone Res. 2021 May 14;9(1):24. doi: 10.1038/s41413-021-00136-2.
4
Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System.
Front Immunol. 2020 Jan 31;11:58. doi: 10.3389/fimmu.2020.00058. eCollection 2020.
5
Osteoimmunology: evolving concepts in bone-immune interactions in health and disease.
Nat Rev Immunol. 2019 Oct;19(10):626-642. doi: 10.1038/s41577-019-0178-8. Epub 2019 Jun 11.
7
Cellular players of hematopoietic stem cell mobilization in the bone marrow niche.
Int J Hematol. 2017 Feb;105(2):129-140. doi: 10.1007/s12185-016-2162-4. Epub 2016 Dec 10.
8
Inflammation, fracture and bone repair.
Bone. 2016 May;86:119-30. doi: 10.1016/j.bone.2016.02.020. Epub 2016 Mar 2.
9
The Hematopoietic Niche in Myeloproliferative Neoplasms.
Mediators Inflamm. 2015;2015:347270. doi: 10.1155/2015/347270. Epub 2015 Nov 30.

本文引用的文献

2
Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization.
J Exp Med. 2011 Oct 24;208(11):2175-81. doi: 10.1084/jem.20101890. Epub 2011 Oct 17.
6
Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs.
Blood. 2010 Dec 2;116(23):4815-28. doi: 10.1182/blood-2009-11-253534. Epub 2010 Aug 16.
7
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.
Blood. 2009 Aug 13;114(7):1331-9. doi: 10.1182/blood-2008-10-184754. Epub 2009 Jan 13.
10
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.
Nat Med. 2006 Jun;12(6):657-64. doi: 10.1038/nm1417. Epub 2006 May 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验